Application of norisoboldine in preparing drugs for preventing and/or treating bladder smooth muscle dysfunction

A technology of desmethylisoboldine and dysfunction, which is applied in the field of bladder smooth muscle dysfunction treatment, can solve the problems of unsatisfactory curative effect and the limitation of clinical application of anticholinergic drugs, and achieve the goal of reducing contractility, contraction and good regulation Effect

Active Publication Date: 2020-05-22
DONGGUAN MATHEMATICAL ENG ACAD OF CHINESE MEDICINE GUANGZHOU UNIV OF CHINESE MEDICINE
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, the treatment methods for overactive bladder mainly include behavior therapy, drug therapy, neuromodulation therapy, etc. In severe cases, detrusor muscle transection or bladde

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of norisoboldine in preparing drugs for preventing and/or treating bladder smooth muscle dysfunction
  • Application of norisoboldine in preparing drugs for preventing and/or treating bladder smooth muscle dysfunction
  • Application of norisoboldine in preparing drugs for preventing and/or treating bladder smooth muscle dysfunction

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Effects of desmethylisoboldine on contractility of detrusor muscle

[0034] Take the mouse bladder, cut the bladder longitudinally into 4 parts with a scalpel (each size is 5-10mm×1-5mm), and tie the two ends of each part into a loop with No. 6 surgical thread, and one end is attached to a fixed On the hook, while the other end is connected to the tension sensor to measure the tension (Harvard Apparatus, USA), the tissue is immersed in an organ bath containing Kreb's solution, the solution is maintained at 37 ° C, and oxygen is continuously passed. The gas composition is as follows: 950mL / L O 2 +50mL / L CO 2 . After acclimatization for 0.5 h in a tension-free state, the bladder tissue was stretched to a tension of 0.5 g and equilibrated for 1 h. Tension changes were displayed on a physiological recorder (Harvard Apparatus, USA & LabChart, New Zealand), and the data were recorded by software (LabChart Software).

[0035] After equilibration, nerve-mediated contraction...

Embodiment 2

[0037] Effects of desmethylisoboldine on the contractility of bladder smooth muscle (DSM) in mice

[0038] 1) Take the mouse bladder, and use a scalpel to cut the bladder longitudinally into 4 parts (5-10 mm x 1-5 mm in size each), and tie the two ends of each part into loops with No. 6 surgical thread, and attach one end to the On the fixed hook, while the other end is connected to the tension sensor to measure the tension (Harvard Apparatus, USA), the tissue is immersed in an organ bath containing Kreb's solution, the solution is maintained at 37 ° C, and oxygen is continuously passed, and the gas composition As follows: 950mL / L O 2 +50mL / L CO 2 . After acclimatization for 0.5 h in a tension-free state, the bladder tissue was stretched to a tension of 0.5 g and equilibrated for 1 h. Tension changes were displayed on a chart recorder (Harvard Apparatus, USA & LabChart, New Zealand) and data were recorded by software (LabChart Software). After tension balance, observe the ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides application of norisoboldine in preparing drugs for preventing and/or treating a bladder smooth muscle dysfunction, and belongs to the technical field of treatment of the bladder smooth muscle dysfunction. The norisoboldine has a very good and obvious regulating function on a bladder smooth muscle function, can lower the contraction ability of detrusor, obviously reduces a contraction response caused to alpha, beta-methylene adenosine 5'-triphosphate (ATP), CCh and KCl by the detrusor, can further obviously reduce contraction caused by electrical field stimulation (EFS),can be used for treating overactive bladder, and can also be used for treating various diseases including uroclepsia, hyperuresis and the like.

Description

technical field [0001] The invention belongs to the technical field of treatment of bladder smooth muscle dysfunction, and in particular relates to the application of desmethylisoboldine in the preparation of medicaments for preventing and / or treating bladder smooth muscle dysfunction. Background technique [0002] The bladder has the functions of storing urine and urinating, and these two functions are realized by the relaxation and contraction of smooth muscle under the regulation of nerves and receptors. Maintaining normal relaxation and contraction of the detrusor muscle is particularly important for maintaining normal urine storage and urination, and changes in bladder function are one of the important factors that cause symptoms of lower urinary tract diseases such as frequent urination, urgency, and urinary incontinence. Alteration of smooth muscle function is not only an important pathogenesis of bladder overactivity or detrusor overactivity, but also a necessary con...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/473A61P13/00A61P13/02A61P13/10
CPCA61K31/473A61P13/00A61P13/02A61P13/10
Inventor 操红缨
Owner DONGGUAN MATHEMATICAL ENG ACAD OF CHINESE MEDICINE GUANGZHOU UNIV OF CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap